antibody-drug conjugate – Page 2 – PROSTATE WARRIORS – The latest news about prostate cancer

Tag Archive for: antibody-drug conjugate

Next-Generation ADCs for Cancer Treatment with Potential in Prostate Cancer

April 24, 2025/in Clinical Trial, Metastatic, Phase 1/by Max

SDV2102: A Promising ADC That Targets PSMA Expressing Tumors

April 19, 2025/in Antibody-Drug Conjugate, Preclinical Research/by Max

TD001: a New Potent ADC for Prostate Cancer Expressing PSMA

April 19, 2025/in Antibody-Drug Conjugate, Preclinical Research/by Max

Phase 1 Soon Recruiting: MK-2400 (Ifinatamab Deruxtecan) for Metastatic Prostate Cancer

April 15, 2025/in Clinical Trial, Metastatic, Phase 1/by Max

FG-3246 Advances to Phase 2 Trial in Prostate Cancer After Promising Early Results

March 6, 2025/in Clinical Trial, Metastatic, Phase 2/by Max

BR111: A New ADC Therapy That Could Work Also For Prostate Cancer

February 11, 2025/in Clinical Trial, Not PCa related/by Max

Phase 1 Trial: CRB-701, A Promising Antibody-Drug Conjugate Targeting Nectin-4

February 3, 2025/in Clinical Trial, Metastatic, Phase 1/by Max

LY4052031 and LY4101174: Other 2 Nectin-4-Targeting Therapy

February 3, 2025/in Clinical Trial, Metastatic, Phase 1/by Max

IPH4502 Phase 1 Clinical Trial for Solid Tumors Expressing Nectin-4

January 24, 2025/in Clinical Trial, Metastatic, Phase 1/by Max

B7-H4-Targeting Antibody-Drug Conjugate, LNCB74, Gets Green Light for Clinical Trials for Solid Tumors

December 11, 2024/in Clinical Trial, Phase 1/by Max